LION Bioscience AG Intents Reorganisation
Advertisement
LION bioscience announced there will be an extraordinary shareholder meeting on March 24, 2005. The reason for the meeting is the management's intention to strategically reorganize the company, which requires changes and enlargements in the company's articles.
The goal of the restructuring is to orient the company towards profitability and shareholder value. This can be achieved by transforming the company into a holding structure and by separating the operating businesses from headquarter functions. With these measures it is expected, that LION will be profitable from on the next fiscal year 2005/2006 starting April 1, 2005.
Most read news
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
QIAGEN Tests Clinically Verified for the Monitoring of Swine Flu - German Bernhard Nocht Institute Unequivocally Detects Infections with the H1N1 Strain Using the artus Influenza Test
Biesterfeld Spezialchemie: New business unit combines healthcare distribution activities
Microbix completes financing for its new state-of-the-art drug manufacturing facility in Toronto
